Doctor-supervised peptide therapy available anywhere in Australia via telehealth. AHPRA-registered prescribers. Licensed compounding pharmacies. Free eligibility assessment with no obligation.
Start free assessment →This page is for general information purposes only. UHD BioHealth is a telehealth-based service available Australia-wide. Peptide therapy requires assessment and prescription from an AHPRA-registered medical practitioner.
Peptide therapy is one of the fastest-growing areas in Australian preventative health. The challenge most Australians face is finding a legitimate service. The market includes everything from properly supervised, doctor-prescribed, pharmacy-prepared protocols to unregulated products shipped from overseas with no clinical oversight at all. Understanding what separates these two categories matters significantly for both safety and outcomes.
A legitimate peptide service in Australia operates within the TGA framework that governs all prescription medicines. This means a valid prescription from an AHPRA-registered medical practitioner, dispensing through a licensed Australian compounding pharmacy, and compounds that have been prepared under quality-controlled pharmaceutical conditions. This is not optional compliance, it is the legal requirement for accessing prescription peptides in Australia.
Services operating outside this framework, whether by providing peptides without a prescription, sourcing from overseas suppliers, or using unlicensed compounding operations, are not operating legally and are exposing their clients to risks that properly supervised services do not carry. The TGA's 2026 safety alert specifically addressed adverse events associated with unregulated peptide products and noted the serious harm that can result.
One of the limitations of the physical clinic model for peptide therapy is geography. Until recently, accessing a doctor who was familiar with peptide therapy and willing to prescribe in a properly supervised context was difficult outside major metropolitan areas. The telehealth model that UHD BioHealth operates on removes this limitation entirely.
Whether you are in Sydney, Melbourne, Brisbane, Perth, Adelaide, or a regional area, the process is identical. Your assessment is completed online, your prescribing doctor reviews your information remotely, your protocol is prepared by a licensed Australian compounding pharmacy, and your compounds are delivered to your address via tracked cold-chain courier.
Complete your health history and goals online. Takes around five minutes and costs nothing.
An AHPRA-registered prescribing doctor reviews your information and prepares a personalised protocol if appropriate.
Once you choose to proceed, your prescription goes to a licensed Australian compounding pharmacy. Cold-chain delivery to your door.
UHD BioHealth clients across Australia have access to the full protocol range covering every major area of peptide therapy. Recovery and injury protocols using BPC-157 and TB-500. Growth hormone pathway protocols using CJC-1295 and Ipamorelin. Longevity protocols using Epitalon, MOTS-c, NAD+ and NMN. Immune health using Thymosin Alpha-1. Weight management using AOD-9604, Tesamorelin, and GLP-1 receptor agonists where appropriate. Skin and collagen using GHK-Cu. Sleep and stress using DSIP, Selank, and Semax. Men's health protocols. And comprehensive multi-compound longevity stacks.
Free assessment, doctor review, licensed pharmacy, cold-chain delivery to your door. The same clinical quality regardless of where you are in Australia.